Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_assertion type Assertion NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_head.
- NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_assertion description "[Although 12% of tumors of the follicular variant of PTC carry BRAF mutations, none of the few oncocytic follicular thyroid adenomas (oncoAd) or carcinomas (oncoFTC) published worldwide tested positive.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_provenance.
- NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_assertion evidence source_evidence_literature NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_provenance.
- NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_assertion SIO_000772 18235983 NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_provenance.
- NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_assertion wasDerivedFrom befree-20150227 NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_provenance.
- NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_assertion wasGeneratedBy ECO_0000203 NP392426.RAVECmgd43N_gb9sYZt0NdEtOdlWU2CZPoL0_n42EhTD0130_provenance.